Scynexis (SCYX) Change in Inventory (2022 - 2023)

Scynexis (SCYX) reported Change in Inventory of $1.5 million for Q4 2023, up 60.66% on a YoY basis from $910000.0 in Q4 2022, and down 48.23% quarter-over-quarter from $2.8 million in Q3 2023.

Scynexis (SCYX) Change in Inventory (2022 - 2023) Analysis & Trends

Scynexis has reported Change in Inventory for 2 years, with the latest figure at $1.5 million in Q4 2023.

  • For the quarter ending Q4 2023, Change in Inventory rose 60.66% year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2024 stood at $1.5 million (down 82.38% YoY), and the FY2023 full-year result was $8.8 million, up 1929.59% from the prior year.
  • Change in Inventory for Q4 2023 stood at $1.5 million, down from $2.8 million in the prior quarter.
  • The five-year high for Change in Inventory was $2.8 million in Q3 2023, with the low at -$797000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -93.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 114.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 40.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -4.30 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 6.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 20.30 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -2.11 Mn
10 Scynexis 225.23 Mn 165.97 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.46 Mn
Dec 31, 2023 1.46 Mn
Sep 30, 2023 2.82 Mn
Sep 30, 2023 2.82 Mn
Jun 30, 2023 1.86 Mn
Jun 30, 2023 1.86 Mn
Mar 31, 2023 2.71 Mn
Mar 31, 2023 2.71 Mn
Dec 31, 2022 910,000.00
Dec 31, 2022 910,000.00
Sep 30, 2022 -797,000.00
Sep 30, 2022 -797,000.00